Search Results 201-210 of 2933 for ✍원벳원 [원탑보증.com/가입코드 111] 올인구조대 ✍

  1. Safety, Tolerability, and Efficacy of GS 9674 in Adults With Primary Biliary Cholangitis Without Cirrhosis - Mayo Clinic

    The primary objective of this study is to evaluate the safety and tolerability of GS-9674 in adults with primary biliary cholangitis (PBC). Participation ...

  2. A Study to Evaluate the Effectiveness and Safety of Glepaglutide in the Treatment of Short Bowel Syndrome - Mayo Clinic

    The primary purpose of this trial is to confirm the effectiveness of glepaglutide in reducing parenteral support volume in patients with short bowel syndrome.

  3. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  4. Everolimus and Brentuximab Vedotin in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Brentuximab vedotin may interfere with the ability of ...

  5. celiac disease marketing campaign landing - video

    ... . VID-20452965. Home; celiac disease marketing campaign landing - video. Double your impact on cancer! Give Now. Make a gift before July 31 and it can ...

  6. Mayo Clinic

    ... . VID-20428724. Home; Gene Guide Lisi. Double your impact on cancer! Give Now. Make a gift before July 31 and it can be doubled in impact thanks to a ...

  7. A Study of Multiple Activity Tracking Devices for Accuracy in Controlled and Free-Walking Conditions - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. I-124 evuzamitide PET/CT Imaging for the Diagnosis of Cardiac Amyloidosis - Mayo Clinic

    The purpose of this study is to evaluate the efficacy of I-124 evuzamitide for diagnosing cardiac amyloidosis. Participation eligibility. Participant ...

  9. A Study of AbGn-107 in Patients With Gastric, Colorectal, or Pancreatic Cancer - Mayo Clinic

    This study is to define the safety profile and to determine the maximum tolerated dose (MTD) and preliminary efficacy of AbGn-107 administered every 28 days (4 ...

  10. MEmbranous Nephropathy Trial Of Rituximab - Mayo Clinic

    The primary outcome of this study is to determine whether or not the B cell targeting with Rituximab is more effective than Cyclosporine in inducing long term ...